Palisade Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Palisade Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,585	Closed	-$323K	–	554
2015 Q3	$323K	Sell	4,585 -114	-2%	-$9.38K	0.01%	483
2015 Q2	$424K	Sell	4,699 -8,840	-65%	-$852K	0.01%	482
2015 Q1	$1.36M	Buy	13,539 +5,262	+64%	+$531K	0.03%	368
2014 Q4	$832K	Buy	8,277 +792	+11%	+$78.9K	0.02%	389
2014 Q3	$720K	Buy	+7,485	New	+$709K	0.02%	401

Other funds holding MJN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Palisade Capital Management's MJN Position: Q4 2015 in Review

Palisade Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 4,585 shares — an estimated $323K sold.

Palisade Capital Management first reported a position in MJN in Q3 2014 and held it in 5 quarters. The position peaked at $1.36M in Q1 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

Palisade Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
Palisade Capital Management sold 4,585 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $323K.
Palisade Capital Management first reported a position in Mead Johnson Nutrition Company in Q3 2014 and held it in 5 quarters.
Palisade Capital Management's Mead Johnson Nutrition Company position peaked at $1.36M in Q1 2015.
549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on Palisade Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.